HIV-1 infection: fooling the gatekeeper.
Cullen
Bryan R
BR
D000818:Animals; D021984:Cyclophilin A / Q000187:drug effects / Q000378:metabolism*; D016572:Cyclosporine / Q000494:pharmacology; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000378:metabolism*; D015497:HIV-1 / Q000472:pathogenicity*; D006801:Humans; D009052:Leukemia Virus, Murine / Q000472:pathogenicity; D051379:Mice; D011323:Primates / Q000502:physiology; D011506:Proteins / Q000235:genetics / Q000378:metabolism; D012190:Retroviridae / Q000472:pathogenicity; D014771:Virion / Q000187:drug effects / Q000378:metabolism*
C103189:Fv1 protein, mouse; D011506:Proteins; D016572:Cyclosporine; C085108:APEX1 protein, human; C486216:Apex1 protein, mouse; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase; D021984:Cyclophilin A